Release Date: 05/05/21 11:50 Summary: Becoming a substantial holder from CBA Price Sensitive: No Download Document 213.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%